Study of the impact of linking of mobile application and cloud service with self-monitoring of blood glucose and sharing with the attending physician on glycometabolism of diabetic patients

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-jRCTs042190057

Enrollment

Registered

2019-07-29

Start date

2019-08-02

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Diabetes mellitus Diabetes mellitus

Interventions

The intervention period is 6 months Install the smart phone application 'smart e-SMBG' Diabetes Treatment Satisfaction Questionnaire 'DTSQ' Self-efficacy scale on health behavior in chronic disease pa

D063731

Smart e-SMBG

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Diabetic patients who perform self-monitoring of blood glucose Patients whose latest HbA1c is 7.0 to 8.9% Patients who have smartphones or tablets that can use smart e-SMBG Patients who have not used smart e-SMBG or similar applications so far Patients who use blood glucose meters that can link smart e-SMBG Patients who are 20 years old or older Patients who understood the research contents and obtained consent

Exclusion criteria

Exclusion criteria: Patients who can not properly operate smart e-SMBG

Design outcomes

Primary

Measure	Time frame
HbA1c	—

Secondary

Measure	Time frame
DTSQ, SE scale Average blood glucose and glucose cariability Hypoglycemic frequency Insulin dose Comparison of these outcomes between type 1 and type 2 diabetes	—

Contacts

Public ContactTakeshi Onoue

Nagoya University Graduate School of Medicine

t-onoue@med.nagoya-u.ac.jp+81-52-744-2142

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026